🇺🇸 Infliximab CT-P13 in United States

Infliximab CT-P13 (Infliximab CT-P13) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Infliximab CT-P13 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Infliximab CT-P13 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Infliximab CT-P13 in United States?

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives is the originator. The local marketing authorisation holder may differ — check the official source linked above.